{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:09:18Z","timestamp":1791256158744,"version":"4.1.0"},"reference-count":239,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T00:00:00Z","timestamp":1783728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Metabolites"],"abstract":"<jats:p>Background\/Objectives: Metabolic-dysfunction-associated steatotic liver disease (MASLD) and metabolic-dysfunction-associated steatohepatitis (MASH) arise in the setting of obesity, insulin resistance, type 2 diabetes, and metabolic syndrome. This review examines how mitochondrial dysfunction participates in the transition from lipid accumulation to hepatocyte injury, inflammation, and fibrosis, and how evidence from human, animal, and in vitro studies should be interpreted. Methods: We provide a narrative synthesis of mechanistic, translational, and clinical studies on hepatic mitochondrial metabolism, fatty acid oxidation, oxidative phosphorylation, redox stress, organelle crosstalk, mitophagy, mitochondrial biogenesis and proteostasis, mitochondrial danger signals, the gut-liver-mitochondria axis, and mitochondria-related therapeutic strategies. Results: In early metabolic overload, mitochondrial oxidation may increase as an adaptive response. With persistent substrate pressure, this adaptation can become inefficient, with impaired fatty acid disposal, less efficient oxidative phosphorylation, reactive oxygen species production, redox imbalance, defective mitochondrial quality control, altered mitochondrial biogenesis, mitochondrial unfolded protein response (UPRmt)-related proteostatic stress and mtDNA instability. Mitochondrial DNA and RNA released from damaged organelles may also activate cyclic GMP-AMP synthase-stimulator of interferon genes (cGAS-STING), inflammasome, and RNA-sensing pathways, linking hepatocyte stress to macrophage activation, stellate cell activation, extracellular matrix deposition, and fibrosis. Conclusions: The current evidence supports mitochondria as a stage-dependent amplifier of metabolic liver injury rather than a uniform initiating event. Clinically, the strongest evidence remains with upstream metabolic unloading and liver-directed metabolic therapy, whereas direct mitochondrial restoration and quality-control targeting remain promising but less mature.<\/jats:p>","DOI":"10.3390\/metabo16070489","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:53:58Z","timestamp":1783932838000},"page":"489","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mitochondrial Dysfunction in Metabolic-Syndrome-Related MASLD\/MASH: Metabolic Mechanisms and Therapeutic Perspectives"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0939-0463","authenticated-orcid":false,"given":"Jin","family":"Jin","sequence":"first","affiliation":[{"name":"Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Institute of Liver Diseases, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Nassir, F. (2022). NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules, 12.","DOI":"10.3390\/biom12060824"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"C1637","DOI":"10.1152\/ajpcell.00951.2024","article-title":"Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease","volume":"328","author":"Kuchay","year":"2025","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3350\/cmh.2022.0237","article-title":"Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis","volume":"29","author":"Lee","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","article-title":"Lipid Disorders and Metabolic-Associated Fatty Liver Disease","volume":"52","author":"Anwar","year":"2023","journal-title":"Endocrinol. Metab. Clin. N. Am."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/978-3-031-63657-8_14","article-title":"Insulin Resistance, Obesity, and Lipotoxicity","volume":"1460","author":"Demir","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","article-title":"Non-alcoholic fatty liver disease\u2014A global public health perspective","volume":"70","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic Steatohepatitis: A Review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10565-025-10128-1","article-title":"From bioinformatics to clinical translation: BIRC5 as a pivotal diagnostic biomarker and therapeutic target for NAFLD-driven HCC","volume":"42","author":"Huang","year":"2025","journal-title":"Cell Biol. Toxicol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: Current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/hep.30251","article-title":"Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1053\/j.gastro.2020.01.052","article-title":"Nonalcoholic Fatty Liver Disease 2020: The State of the Disease","volume":"158","author":"Cotter","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3920196","DOI":"10.1155\/2020\/3920196","article-title":"The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)","volume":"2020","author":"Tanase","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: Biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jhep.2022.09.020","article-title":"Mitochondrial alterations in fatty liver diseases","volume":"78","author":"Fromenty","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s12967-023-04367-1","article-title":"Mitochondrial metabolic dysfunction and non-alcoholic fatty liver disease: New insights from pathogenic mechanisms to clinically targeted therapy","volume":"21","author":"Zheng","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2025.02.033","article-title":"Integrative metabolism in MASLD and MASH: Pathophysiology and emerging mechanisms","volume":"83","author":"Steinberg","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhao, Y., Zhou, Y., Wang, D., Huang, Z., Xiao, X., Zheng, Q., Li, S., Long, D., and Feng, L. (2023). Mitochondrial Dysfunction in Metabolic Dysfunction Fatty Liver Disease (MAFLD). Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms242417514"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00018-023-05061-7","article-title":"Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction","volume":"81","author":"LeFort","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1053\/j.gastro.2019.11.311","article-title":"Mechanisms of Fibrosis Development in Nonalcoholic Steatohepatitis","volume":"158","author":"Schwabe","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/j.2040-4603.2014.tb00548.x","article-title":"Energy metabolism in the liver","volume":"4","author":"Rui","year":"2014","journal-title":"Compr. Physiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"155614","DOI":"10.1016\/j.metabol.2023.155614","article-title":"Roles of malate and aspartate in gluconeogenesis in various physiological and pathological states","volume":"145","year":"2023","journal-title":"Metabolism"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Erdal, R., Birsoy, K., and Unlu, G. (2025). Amino Acid Metabolism in Liver Mitochondria: From Homeostasis to Disease. Metabolites, 15.","DOI":"10.3390\/metabo15070446"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"100780","DOI":"10.1016\/j.jhepr.2023.100780","article-title":"Role of ammonia in NAFLD: An unusual suspect","volume":"5","author":"Thomsen","year":"2023","journal-title":"JHEP Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/MOL.0b013e3283462e16","article-title":"Hepatic fatty acid partitioning","volume":"22","author":"Hodson","year":"2011","journal-title":"Curr. Opin. Lipidol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1582-4934.2009.00997.x","article-title":"FXR an emerging therapeutic target for the treatment of atherosclerosis","volume":"14","author":"Mencarelli","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1172\/JCI88888","article-title":"Cardiac nuclear receptors: Architects of mitochondrial structure and function","volume":"127","author":"Vega","year":"2017","journal-title":"J. Clin. Investig."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Vargas-Ortiz, K., P\u00e9rez-V\u00e1zquez, V., and Mac\u00edas-Cervantes, M.H. (2019). Exercise and Sirtuins: A Way to Mitochondrial Health in Skeletal Muscle. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20112717"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/1073858415585472","article-title":"Mitochondria: Major Regulators of Neural Development","volume":"22","author":"Xavier","year":"2016","journal-title":"Neuroscientist"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Ramanathan, R., Ali, A.H., and Ibdah, J.A. (2022). Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23137280"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kolb, H., Kempf, K., R\u00f6hling, M., Lenzen-Schulte, M., Schloot, N.C., and Martin, S. (2021). Ketone bodies: From enemy to friend and guardian angel. BMC Med., 19.","DOI":"10.1186\/s12916-021-02185-0"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.2337\/dbi22-0003","article-title":"Regulation of Hepatic Lipid and Glucose Metabolism by INSP3R1","volume":"71","author":"Perry","year":"2022","journal-title":"Diabetes"},{"key":"ref_35","first-page":"1","article-title":"Triglyceride Metabolism in the Liver","volume":"8","author":"Cohen","year":"2017","journal-title":"Compr. Physiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12072-020-10121-2","article-title":"How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?","volume":"15","author":"Geng","year":"2021","journal-title":"Hepatol. Int."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"29834","DOI":"10.1074\/jbc.M110.139493","article-title":"Evidence for physical association of mitochondrial fatty acid oxidation and oxidative phosphorylation complexes","volume":"285","author":"Wang","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/j.gastro.2018.06.083","article-title":"Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases","volume":"155","author":"Mansouri","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Eyenga, P., Rey, B., Eyenga, L., and Sheu, S.S. (2022). Regulation of Oxidative Phosphorylation of Liver Mitochondria in Sepsis. Cells, 11.","DOI":"10.3390\/cells11101598"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1440-1681.12886","article-title":"Role of mitochondria and mitochondria-targeted agents in non-alcoholic fatty liver disease","volume":"45","author":"Ajith","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"ref_42","first-page":"160","article-title":"Redox state and methods to evaluate oxidative stress in liver damage: From bench to bedside","volume":"15","author":"Arauz","year":"2016","journal-title":"Ann. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1874467208666150817111114","article-title":"Role of CYP2E1 in Mitochondrial Dysfunction and Hepatic Injury by Alcohol and Non-Alcoholic Substances","volume":"10","author":"Abdelmegeed","year":"2017","journal-title":"Curr. Mol. Pharmacol."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Chen, T.H., Wang, H.C., Chang, C.J., and Lee, S.Y. (2024). Mitochondrial Glutathione in Cellular Redox Homeostasis and Disease Manifestation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25021314"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/bph.14498","article-title":"Disulfide reductase systems in liver","volume":"176","author":"Miller","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"39764","DOI":"10.1038\/srep39764","article-title":"Cytochrome P450-2E1 promotes fast food-mediated hepatic fibrosis","volume":"7","author":"Abdelmegeed","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"10180","DOI":"10.3748\/wjg.v22.i46.10180","article-title":"Hepatoprotective and antioxidant effects of lycopene on non-alcoholic fatty liver disease in rat","volume":"22","author":"Jiang","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.nutres.2016.06.015","article-title":"Sesamin ameliorates hepatic steatosis and inflammation in rats on a high-fat diet via LXR\u03b1 and PPAR\u03b1","volume":"36","author":"Zhang","year":"2016","journal-title":"Nutr. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.tem.2016.11.006","article-title":"Mitochondrial Adaptation in Nonalcoholic Fatty Liver Disease: Novel Mechanisms and Treatment Strategies","volume":"28","author":"Sunny","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","article-title":"Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease","volume":"75","author":"Ipsen","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.biochi.2016.11.009","article-title":"PPARs and nonalcoholic fatty liver disease","volume":"136","author":"Liss","year":"2017","journal-title":"Biochimie"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s12276-023-01072-3","article-title":"MicroRNA regulation of AMPK in nonalcoholic fatty liver disease","volume":"55","author":"Sun","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zeng, C., and Chen, M. (2022). Progress in Nonalcoholic Fatty Liver Disease: SIRT Family Regulates Mitochondrial Biogenesis. Biomolecules, 12.","DOI":"10.3390\/biom12081079"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1194\/jlr.M080952","article-title":"Regulation of mitochondrial trifunctional protein modulates nonalcoholic fatty liver disease in mice","volume":"59","author":"Nassir","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"101115","DOI":"10.1016\/j.gendis.2023.101115","article-title":"Mitochondrial dysfunction: A promising therapeutic target for liver diseases","volume":"11","author":"Chen","year":"2024","journal-title":"Genes Dis."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.08.009","article-title":"Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output","volume":"183","author":"Zhao","year":"2020","journal-title":"Cell"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"L\u00e9veill\u00e9, M., and Estall, J.L. (2019). Mitochondrial Dysfunction in the Transition from NASH to HCC. Metabolites, 9.","DOI":"10.3390\/metabo9100233"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/s41574-021-00507-z","article-title":"Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus","volume":"17","author":"Ferguson","year":"2021","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/s41580-021-00390-6","article-title":"The aetiology and molecular landscape of insulin resistance","volume":"22","author":"James","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1042\/BCJ20210071","article-title":"SREBP-1c and lipogenesis in the liver: An update1","volume":"478","author":"Phan","year":"2021","journal-title":"Biochem. J."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"101238","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1096\/fj.201601156R","article-title":"Ceramides and mitochondrial fatty acid oxidation in obesity","volume":"31","author":"Fucho","year":"2017","journal-title":"FASEB J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e180310","DOI":"10.1172\/JCI180310","article-title":"The senescence-associated secretome of Hedgehog-deficient hepatocytes drives MASLD progression","volume":"134","author":"Jun","year":"2024","journal-title":"J. Clin. Investig."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"e0365","DOI":"10.1097\/HC9.0000000000000365","article-title":"mARC1 in MASLD: Modulation of lipid accumulation in human hepatocytes and adipocytes","volume":"8","author":"Jones","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.ajpath.2023.08.007","article-title":"The Role of Endoplasmic Reticulum in Lipotoxicity during Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Pathogenesis","volume":"193","author":"Venkatesan","year":"2023","journal-title":"Am. J. Pathol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154589","DOI":"10.1016\/j.phymed.2022.154589","article-title":"Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function","volume":"109","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Tapia, M., Tob\u00f3n-Cornejo, S., Noriega, L.G., V\u00e1zquez-Manjarrez, N., Couti\u00f1o-Hern\u00e1ndez, D., Granados-Portillo, O., Rom\u00e1n-Calleja, B.M., Ru\u00edz-Marg\u00e1in, A., Mac\u00edas-Rodr\u00edguez, R.U., and Tovar, A.R. (2024). Hepatic Steatosis Can Be Partly Generated by the Gut Microbiota-Mitochondria Axis via 2-Oleoyl Glycerol and Reversed by a Combination of Soy Protein, Chia Oil, Curcumin and Nopal. Nutrients, 16.","DOI":"10.20944\/preprints202407.0745.v1"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e0310","DOI":"10.1097\/HC9.0000000000000310","article-title":"Gut microbiota and metabolic biomarkers in metabolic dysfunction-associated steatotic liver disease","volume":"8","author":"Long","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Lu, Q., Tian, X., Wu, H., Huang, J., Li, M., Mei, Z., Zhou, L., Xie, H., and Zheng, S. (2021). Metabolic Changes of Hepatocytes in NAFLD. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.710420"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Kattapuram, N., Zhang, C., Muyyarikkandy, M.S., Surugihalli, C., Muralidaran, V., Gregory, T., and Sunny, N.E. (2021). Dietary Macronutrient Composition Differentially Modulates the Remodeling of Mitochondrial Oxidative Metabolism during NAFLD. Metabolites, 11.","DOI":"10.3390\/metabo11050272"},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Fahlbusch, P., Nikolic, A., Hartwig, S., Jacob, S., Kettel, U., K\u00f6llmer, C., Al-Hasani, H., Lehr, S., M\u00fcller-Wieland, D., and Knebel, B. (2022). Adaptation of Oxidative Phosphorylation Machinery Compensates for Hepatic Lipotoxicity in Early Stages of MAFLD. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23126873"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"E749","DOI":"10.1152\/ajpendo.00178.2016","article-title":"Aerobic capacity and hepatic mitochondrial lipid oxidation alters susceptibility for chronic high-fat diet-induced hepatic steatosis","volume":"311","author":"Morris","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"e99762","DOI":"10.1172\/jci.insight.99762","article-title":"Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome","volume":"3","author":"Puchalska","year":"2018","journal-title":"JCI Insight"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1038\/s41467-022-30629-5","article-title":"Influence of NAFLD and bariatric surgery on hepatic and adipose tissue mitochondrial biogenesis and respiration","volume":"13","author":"Pedersen","year":"2022","journal-title":"Nat. Commun."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.2337\/db20-1228","article-title":"Critical Role for Hepatocyte-Specific eNOS in NAFLD and NASH","volume":"70","author":"Cunningham","year":"2021","journal-title":"Diabetes"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Rafiei, H., Omidian, K., and Bandy, B. (2019). Dietary Polyphenols Protect Against Oleic Acid-Induced Steatosis in an In Vitro Model of NAFLD by Modulating Lipid Metabolism and Improving Mitochondrial Function. Nutrients, 11.","DOI":"10.3390\/nu11030541"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"101314","DOI":"10.1016\/j.redox.2019.101314","article-title":"Carbon monoxide releasing molecule-A1 improves nonalcoholic steatohepatitis via Nrf2 activation mediated improvement in oxidative stress and mitochondrial function","volume":"28","author":"Upadhyay","year":"2020","journal-title":"Redox Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"44408","DOI":"10.1038\/srep44408","article-title":"Hepatic mitochondrial dysfunction is a feature of Glycogen Storage Disease Type Ia (GSDIa)","volume":"7","author":"Farah","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.3748\/wjg.v26.i34.5101","article-title":"Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation","volume":"26","author":"Bilbao","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Sim\u00f5es, I.C.M., Amorim, R., Teixeira, J., Karkucinska-Wieckowska, A., Carvalho, A., Pereira, S.P., Sim\u00f5es, R.F., Szymanska, S., D\u0105browski, M., and Janikiewicz, J. (2021). The Alterations of Mitochondrial Function during NAFLD Progression\u2014An Independent Effect of Mitochondrial ROS Production. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22136848"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"107159","DOI":"10.1016\/j.jbc.2024.107159","article-title":"Fatty acid oxidation drives mitochondrial hydrogen peroxide production by \u03b1-ketoglutarate dehydrogenase","volume":"300","author":"Grayson","year":"2024","journal-title":"J. Biol. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Arroyave-Ospina, J.C., Wu, Z., Geng, Y., and Moshage, H. (2021). Role of Oxidative Stress in the Pathogenesis of Non-Alcoholic Fatty Liver Disease: Implications for Prevention and Therapy. Antioxidants, 10.","DOI":"10.3390\/antiox10020174"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"6889533","DOI":"10.1155\/2021\/6889533","article-title":"The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD","volume":"2021","author":"Hong","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"e162533","DOI":"10.1172\/JCI162533","article-title":"Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity","volume":"134","author":"Greatorex","year":"2023","journal-title":"J. Clin. Investig."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Zhao, S., Guo, Y., and Yin, X. (2023). Lipid Peroxidation in Ferroptosis and Association with Nonalcoholic Fatty Liver Disease. Front. Biosci. (Landmark Ed.), 28.","DOI":"10.31083\/j.fbl2812332"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/978-3-031-63657-8_18","article-title":"Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis","volume":"1460","author":"Engin","year":"2024","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"102582","DOI":"10.1016\/j.redox.2022.102582","article-title":"Microbiota-induced lipid peroxidation impairs obeticholic acid-mediated antifibrotic effect towards nonalcoholic steatohepatitis in mice","volume":"59","author":"Zhuge","year":"2023","journal-title":"Redox Biol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e1900833","DOI":"10.1002\/mnfr.201900833","article-title":"Lipoatrophy-Associated Insulin Resistance and Hepatic Steatosis are Attenuated by Intake of Diet Rich in Omega 3 Fatty Acids","volume":"64","author":"Moreira","year":"2020","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"103159","DOI":"10.1016\/j.redox.2024.103159","article-title":"SLC7A11-ROS\/\u03b1KG-AMPK axis regulates liver inflammation through mitophagy and impairs liver fibrosis and NASH progression","volume":"72","author":"Lv","year":"2024","journal-title":"Redox Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jhep.2023.03.016","article-title":"ATF4 suppresses hepatocarcinogenesis by inducing SLC7A11 (xCT) to block stress-related ferroptosis","volume":"79","author":"He","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jare.2023.02.012","article-title":"FUNDC1 interacts with GPx4 to govern hepatic ferroptosis and fibrotic injury through a mitophagy-dependent manner","volume":"55","author":"Bi","year":"2024","journal-title":"J. Adv. Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"e2402241","DOI":"10.1002\/advs.202402241","article-title":"IL6 Derived from Macrophages under Intermittent Hypoxia Exacerbates NAFLD by Promoting Ferroptosis via MARCH3-Led Ubiquitylation of GPX4","volume":"11","author":"Cai","year":"2024","journal-title":"Adv. Sci."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jhep.2024.04.009","article-title":"Targeting EFHD2 inhibits interferon-\u03b3 signaling and ameliorates non-alcoholic steatohepatitis","volume":"81","author":"Fu","year":"2024","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Ma, X., Qian, H., Chen, A., Ni, H.M., and Ding, W.X. (2021). Perspectives on Mitochondria-ER and Mitochondria-Lipid Droplet Contact in Hepatocytes and Hepatic Lipid Metabolism. Cells, 10.","DOI":"10.3390\/cells10092273"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"159030","DOI":"10.1016\/j.bbalip.2021.159030","article-title":"Loss and gain of function of Grp75 or mitofusin 2 distinctly alter cholesterol metabolism, but all promote triglyceride accumulation in hepatocytes","volume":"1866","author":"Bassot","year":"2021","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.scib.2021.10.014","article-title":"Hepatic CDP-diacylglycerol synthase 2 deficiency causes mitochondrial dysfunction and promotes rapid progression of NASH and fibrosis","volume":"67","author":"Xu","year":"2022","journal-title":"Sci. Bull."},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Chen, C.C., Hsu, L.W., Chen, K.D., Chiu, K.W., Chen, C.L., and Huang, K.T. (2021). Emerging Roles of Calcium Signaling in the Development of Non-Alcoholic Fatty Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010256"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e2410486121","DOI":"10.1073\/pnas.2410486121","article-title":"ER-tethered stress sensor CREBH regulates mitochondrial unfolded protein response to maintain energy homeostasis","volume":"121","author":"Kim","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"177509","DOI":"10.1016\/j.ejphar.2025.177509","article-title":"Pharmacological landscape of endoplasmic reticulum stress: Uncovering therapeutic avenues for metabolic diseases","volume":"998","author":"Alotaibi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.freeradbiomed.2022.06.226","article-title":"Nonalcoholic steatohepatitis and mechanisms by which it is ameliorated by activation of the CNC-bZIP transcription factor Nrf2","volume":"188","author":"Bathish","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00125-021-05488-2","article-title":"Non-alcoholic fatty liver disease in mice with hepatocyte-specific deletion of mitochondrial fission factor","volume":"64","author":"Takeichi","year":"2021","journal-title":"Diabetologia"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/s41467-023-38165-6","article-title":"Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease","volume":"14","author":"Zeng","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1002\/hep4.1785","article-title":"ROR\u03b1 Enhances Lysosomal Acidification and Autophagic Flux in the Hepatocytes","volume":"5","author":"Kim","year":"2021","journal-title":"Hepatol. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1080\/15548627.2020.1834711","article-title":"TXNIP\/VDUP1 attenuates steatohepatitis via autophagy and fatty acid oxidation","volume":"17","author":"Park","year":"2021","journal-title":"Autophagy"},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Sinha, R.A., Rajak, S., Singh, B.K., and Yen, P.M. (2020). Hepatic Lipid Catabolism via PPAR\u03b1-Lysosomal Crosstalk. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21072391"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/15548627.2021.1933742","article-title":"Autophagy in metabolism and quality control: Opposing, complementary or interlinked functions?","volume":"18","author":"Deretic","year":"2022","journal-title":"Autophagy"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Tahri-Joutey, M., Andreoletti, P., Surapureddi, S., Nasser, B., Cherkaoui-Malki, M., and Latruffe, N. (2021). Mechanisms Mediating the Regulation of Peroxisomal Fatty Acid Beta-Oxidation by PPAR\u03b1. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22168969"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"G483","DOI":"10.1152\/ajpgi.00281.2023","article-title":"Interaction between fatty acid oxidation and ethanol metabolism in liver","volume":"326","author":"Lu","year":"2024","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"116241","DOI":"10.1016\/j.bcp.2024.116241","article-title":"The fatty acid omega hydroxylase genes (CYP4 family) in the progression of metabolic dysfunction-associated steatotic liver disease (MASLD): An RNA sequence database analysis and review","volume":"228","author":"Leahy","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Vinoy, N., Huang, G., Wallace, D.F., and Subramaniam, V.N. (2025). Peroxisome Dysfunction and Steatotic Liver Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26178303"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"e13918","DOI":"10.1111\/apha.13918","article-title":"Heme oxygenase-1 prevents non-alcoholic steatohepatitis through modulating mitochondrial quality control","volume":"237","author":"Li","year":"2023","journal-title":"Acta Physiol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s13679-022-00473-1","article-title":"Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Legaki","year":"2022","journal-title":"Curr. Obes. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cell Metab."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2174\/0115665240275594231229121030","article-title":"Pharmacological Activation of AMPK Prevents Drp1-mediated Mitochondrial Fission and Alleviates Hepatic Steatosis In Vitro","volume":"24","author":"Du","year":"2024","journal-title":"Curr. Mol. Med."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.yjmcc.2015.07.010","article-title":"Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction","volume":"86","author":"Li","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"4192","DOI":"10.7150\/thno.21400","article-title":"Pro-Inflammatory CXCR3 Impairs Mitochondrial Function in Experimental Non-Alcoholic Steatohepatitis","volume":"7","author":"Du","year":"2017","journal-title":"Theranostics"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"101566","DOI":"10.1016\/j.molmet.2022.101566","article-title":"The mitochondrial fission protein Drp1 in liver is required to mitigate NASH and prevents the activation of the mitochondrial ISR","volume":"64","author":"Steffen","year":"2022","journal-title":"Mol. Metab."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Joaquim, M., and Escobar-Henriques, M. (2020). Role of Mitofusins and Mitophagy in Life or Death Decisions. Front. Cell Dev. Biol., 8.","DOI":"10.3389\/fcell.2020.572182"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.cmet.2018.06.014","article-title":"Mitochondrial Stasis Reveals p62-Mediated Ubiquitination in Parkin-Independent Mitophagy and Mitigates Nonalcoholic Fatty Liver Disease","volume":"28","author":"Yamada","year":"2018","journal-title":"Cell Metab."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"16041","DOI":"10.1038\/s41598-017-16077-y","article-title":"Liver-specific deletion of ROR\u03b1 aggravates diet-induced nonalcoholic steatohepatitis by inducing mitochondrial dysfunction","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13578-016-0113-7","article-title":"Thyroid hormone-mediated autophagy and mitochondrial turnover in NAFLD","volume":"6","author":"Sinha","year":"2016","journal-title":"Cell Biosci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"114678","DOI":"10.1016\/j.intimp.2025.114678","article-title":"TJ0113 attenuates fibrosis in metabolic dysfunction-associated steatohepatitis by inducing mitophagy","volume":"156","author":"Huang","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00125-023-05869-9","article-title":"Chaperonin counteracts diet-induced non-alcoholic fatty liver disease by aiding sirtuin 3 in the control of fatty acid oxidation","volume":"66","author":"Weng","year":"2023","journal-title":"Diabetologia"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12967-024-04880-x","article-title":"(+)-Lipoic acid reduces mitochondrial unfolded protein response and attenuates oxidative stress and aging in an in vitro model of non-alcoholic fatty liver disease","volume":"22","author":"Longhitano","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jhep.2025.07.013","article-title":"Decreased LONP1 expression exacerbates MASH-induced liver fibrosis via elevated orotic acid levels","volume":"84","author":"Xu","year":"2026","journal-title":"J. Hepatol."},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Chen, C.L., Huang, F.F., Lin, H.F., Wu, C.C., Ni, Y.H., and Lin, Y.C. (2024). Tat-Beclin-1 Peptide Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Enhancing Hepatic Autophagy. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212372"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.3748\/wjg.v22.i31.6965","article-title":"Mitochondrial DNA from hepatocytes as a ligand for TLR9: Drivers of nonalcoholic steatohepatitis?","volume":"22","author":"Handa","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"116464","DOI":"10.1016\/j.lfs.2019.05.020","article-title":"Mitochondrial DNA in liver inflammation and oxidative stress","volume":"236","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"100324","DOI":"10.1016\/j.jhepr.2021.100324","article-title":"The role of cGAS-STING signalling in liver diseases","volume":"3","author":"Chen","year":"2021","journal-title":"JHEP Rep."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Lee, A.H., Oh, J.H., Kim, H.S., Shin, J.H., Yoon, E.L., and Jun, D.W. (2022). Peripheral blood mononuclear cell mitochondrial copy number and adenosine triphosphate inhibition test in NAFLD. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.967848"},{"key":"ref_131","doi-asserted-by":"crossref","unstructured":"Giacco, A., Petito, G., Silvestri, E., Scopigno, N., Vigliotti, M., Mercurio, G., de Lange, P., Lombardi, A., Moreno, M., and Goglia, F. (2024). Comparative effects of 3,5-diiodo-L-thyronine and 3,5,3\u2032-triiodo-L-thyronine on mitochondrial damage and cGAS\/STING-driven inflammation in liver of hypothyroid rats. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1432819"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/labinvest.2011.55","article-title":"Fatty liver is associated with impaired activity of PPAR\u03b3-coactivator 1\u03b1 (PGC1\u03b1) and mitochondrial biogenesis in mice","volume":"91","author":"Pen","year":"2011","journal-title":"Lab. Investig."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10522-023-10023-4","article-title":"Early-onset caloric restriction alleviates ageing-associated steatohepatitis in male mice via restoring mitochondrial homeostasis","volume":"24","author":"Chiang","year":"2023","journal-title":"Biogerontology"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"G1034","DOI":"10.1152\/ajpgi.00431.2020","article-title":"Mitochondrial DNA enables AIM2 inflammasome activation and hepatocyte pyroptosis in nonalcoholic fatty liver disease","volume":"320","author":"Xu","year":"2021","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cellimm.2018.08.006","article-title":"Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release","volume":"332","author":"Pan","year":"2018","journal-title":"Cell. Immunol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"100555","DOI":"10.1016\/j.jhepr.2022.100555","article-title":"XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression","volume":"4","author":"Wang","year":"2022","journal-title":"JHEP Rep."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Huang, Y.H., Wang, F.S., Wang, P.W., Lin, H.Y., Luo, S.D., and Yang, Y.L. (2022). Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23010577"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"10992","DOI":"10.1038\/s41467-025-66159-z","article-title":"Mitochondrial RNA cytosolic leakage drives the SASP","volume":"16","author":"Victorelli","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_140","first-page":"8158","article-title":"Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation","volume":"23","author":"Liu","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1194\/jlr.M083741","article-title":"Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis, and NLRP3 activation in mice","volume":"59","author":"Schuster","year":"2018","journal-title":"J. Lipid Res."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.3748\/wjg.v24.i40.4519","article-title":"Extracellular vesicles in liver disease and beyond","volume":"24","author":"Cubero","year":"2018","journal-title":"World J. Gastroenterol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1053\/j.gastro.2020.06.031","article-title":"IRE1A Stimulates Hepatocyte-Derived Extracellular Vesicles That Promote Inflammation in Mice With Steatohepatitis","volume":"159","author":"Dasgupta","year":"2020","journal-title":"Gastroenterology"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Liao, C.Y., Song, M.J., Gao, Y., Mauer, A.S., Revzin, A., and Malhi, H. (2018). Hepatocyte-Derived Lipotoxic Extracellular Vesicle Sphingosine 1-Phosphate Induces Macrophage Chemotaxis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02980"},{"key":"ref_145","doi-asserted-by":"crossref","unstructured":"Dorairaj, V., Sulaiman, S.A., Abu, N., and Abdul Murad, N.A. (2020). Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update. Biomolecules, 10.","DOI":"10.3390\/biom10111494"},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Wu, D., Zhu, H., and Wang, H. (2021). Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.707429"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Mu\u00f1oz-Hern\u00e1ndez, R., Rojas, \u00c1., Gato, S., Gallego, J., Gil-G\u00f3mez, A., Castro, M.J., Ampuero, J., and Romero-G\u00f3mez, M. (2022). Extracellular Vesicles as Biomarkers in Liver Disease. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416217"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.jhep.2021.07.032","article-title":"Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis","volume":"75","author":"Wang","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_149","doi-asserted-by":"crossref","unstructured":"Her, Z., Tan, J.H.L., Lim, Y.S., Tan, S.Y., Chan, X.Y., Tan, W.W.S., Liu, M., Yong, K.S.M., Lai, F., and Ceccarello, E. (2020). CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.580968"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/hep.29544","article-title":"Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis","volume":"67","author":"Krenkel","year":"2018","journal-title":"Hepatology"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","article-title":"Hepatic stellate cells as key target in liver fibrosis","volume":"121","author":"Higashi","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.cmet.2016.09.016","article-title":"Hepatocyte TAZ\/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis","volume":"24","author":"Wang","year":"2016","journal-title":"Cell Metab."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"eaat0344","DOI":"10.1126\/scitranslmed.aat0344","article-title":"Hepatocyte Notch activation induces liver fibrosis in nonalcoholic steatohepatitis","volume":"10","author":"Zhu","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"e162402","DOI":"10.1172\/jci.insight.162402","article-title":"Increased CHCHD2 expression promotes liver fibrosis in nonalcoholic steatohepatitis via Notch\/osteopontin signaling","volume":"7","author":"Li","year":"2022","journal-title":"JCI Insight"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.cmet.2022.07.006","article-title":"Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis","volume":"34","author":"Gao","year":"2022","journal-title":"Cell Metab."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"101401","DOI":"10.1016\/j.xcrm.2024.101401","article-title":"p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway","volume":"5","author":"Fondevila","year":"2024","journal-title":"Cell Rep. Med."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s11658-024-00596-4","article-title":"Lipotoxic hepatocyte derived LIMA1 enriched small extracellular vesicles promote hepatic stellate cells activation via inhibiting mitophagy","volume":"29","author":"Li","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/hep.32662","article-title":"Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis","volume":"77","author":"Liu","year":"2023","journal-title":"Hepatology"},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Koenen, M.T., Brandt, E.F., Kaczor, D.M., Caspers, T., Heinzmann, A.C.A., Fischer, P., Heinrichs, D., Wirtz, T.H., Trautwein, C., and Koenen, R.R. (2022). Extracellular Vesicles from Steatotic Hepatocytes Provoke Pro-Fibrotic Responses in Cultured Stellate Cells. Biomolecules, 12.","DOI":"10.3390\/biom12050698"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1053\/j.gastro.2019.05.002","article-title":"Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis","volume":"157","author":"Widjaja","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1038\/s41467-023-37453-5","article-title":"MAIT cell inhibition promotes liver fibrosis regression via macrophage phenotype reprogramming","volume":"14","author":"Mabire","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"e195242","DOI":"10.1172\/jci.insight.195242","article-title":"ETS1 suppresses hepatic stellate cell activation and liver fibrosis","volume":"10","author":"Lee","year":"2025","journal-title":"JCI Insight"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1146\/annurev-nutr-071715-050656","article-title":"Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus","volume":"36","author":"Koliaki","year":"2016","journal-title":"Annu. Rev. Nutr."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"101134","DOI":"10.1016\/j.molmet.2020.101134","article-title":"Mitochondrial oxidative function in NAFLD: Friend or foe?","volume":"50","author":"Shum","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e70132","DOI":"10.1002\/edm2.70132","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances","volume":"8","author":"Miller","year":"2025","journal-title":"Endocrinol. Diabetes Metab."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"224","DOI":"10.7570\/jomes25017","article-title":"Metabolic Dysfunction-Associated Steatotic Liver Disease Complicated by Diabetes: Pathophysiology and Emerging Therapies","volume":"34","author":"Goto","year":"2025","journal-title":"J. Obes. Metab. Syndr."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/hep.21813","article-title":"The effects of 48 weeks of rosiglitazone on hepatocyte mitochondria in human nonalcoholic steatohepatitis","volume":"46","author":"Caldwell","year":"2007","journal-title":"Hepatology"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/hep.32324","article-title":"Compromised hepatic mitochondrial fatty acid oxidation and reduced markers of mitochondrial turnover in human NAFLD","volume":"76","author":"Moore","year":"2022","journal-title":"Hepatology"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/path.4803","article-title":"Mitochondrial genome architecture in non-alcoholic fatty liver disease","volume":"240","author":"Sookoian","year":"2016","journal-title":"J. Pathol."},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Kakehashi, A., Stefanov, V.E., Ishii, N., Okuno, T., Fujii, H., Kawai, K., Kawada, N., and Wanibuchi, H. (2017). Proteome Characteristics of Non-Alcoholic Steatohepatitis Liver Tissue and Associated Hepatocellular Carcinomas. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18020434"},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.1021\/acs.jafc.3c09132","article-title":"Elevated PINK1\/Parkin-Dependent Mitophagy and Boosted Mitochondrial Function Mediate Protection of HepG2 Cells from Excess Palmitic Acid by Hesperetin","volume":"72","author":"Li","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3350\/cmh.2021.0127","article-title":"Recent advances in nonalcoholic fatty liver disease metabolomics","volume":"27","author":"Kim","year":"2021","journal-title":"Clin. Mol. Hepatol."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Piras, C., Noto, A., Ibba, L., Deidda, M., Fanos, V., Muntoni, S., Leoni, V.P., and Atzori, L. (2021). Contribution of Metabolomics to the Understanding of NAFLD and NASH Syndromes: A Systematic Review. Metabolites, 11.","DOI":"10.3390\/metabo11100694"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"119054","DOI":"10.1016\/j.atherosclerosis.2024.119054","article-title":"Liver metabolism in human MASLD: A review of recent advancements using human tissue metabolomics","volume":"400","author":"Flam","year":"2025","journal-title":"Atherosclerosis"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"G100","DOI":"10.1152\/ajpgi.00329.2014","article-title":"Metformin prevents ischemia reperfusion-induced oxidative stress in the fatty liver by attenuation of reactive oxygen species formation","volume":"309","author":"Cahova","year":"2015","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3961748","DOI":"10.1155\/2018\/3961748","article-title":"Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients","volume":"2018","author":"Wu","year":"2018","journal-title":"Biomed. Res. Int."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.jaim.2021.04.007","article-title":"Intervention by picroside II on FFAs induced lipid accumulation and lipotoxicity in HepG2 cells","volume":"12","author":"Vaidya","year":"2021","journal-title":"J. Ayurveda Integr. Med."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1186\/s12967-023-04431-w","article-title":"ACLY as a modulator of liver cell functions and its role in Metabolic Dysfunction-Associated Steatohepatitis","volume":"21","author":"Convertini","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Prola, A., and Pilot-Storck, F. (2022). Cardiolipin Alterations during Obesity: Exploring Therapeutic Opportunities. Biology, 11.","DOI":"10.3390\/biology11111638"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"9986299","DOI":"10.1155\/2021\/9986299","article-title":"Changes in Key Mitochondrial Lipids Accompany Mitochondrial Dysfunction and Oxidative Stress in NAFLD","volume":"2021","author":"Durand","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_182","first-page":"653","article-title":"Changes of cardiolipin involve in the occurrence and development of mitochondrial dysfunction associated with non-alcoholic fatty liver disease","volume":"46","author":"Wu","year":"2021","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.freeradbiomed.2021.08.232","article-title":"Mitochondrial dysfunction in mouse livers depleted of iron chaperone PCBP1","volume":"175","author":"Jadhav","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"e40774","DOI":"10.5812\/hepatmon.40774","article-title":"Liver Mitochondrial DNA Copy Number and Deletion Levels May Contribute to Nonalcoholic Fatty Liver Disease Susceptibility","volume":"16","author":"Kamfar","year":"2016","journal-title":"Hepat. Mon."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1111\/j.1582-4934.2010.01128.x","article-title":"High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia","volume":"15","author":"Carabelli","year":"2011","journal-title":"J. Cell. Mol. Med."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Malik, A.N., Sim\u00f5es, I.C.M., Rosa, H.S., Khan, S., Karkucinska-Wieckowska, A., and Wieckowski, M.R. (2019). A Diet Induced Maladaptive Increase in Hepatic Mitochondrial DNA Precedes OXPHOS Defects and May Contribute to Non-Alcoholic Fatty Liver Disease. Cells, 8.","DOI":"10.3390\/cells8101222"},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"Di Mauro, S., Scamporrino, A., Filippello, A., Di Pino, A., Scicali, R., Malaguarnera, R., Purrello, F., and Piro, S. (2021). Clinical and Molecular Biomarkers for Diagnosis and Staging of NAFLD. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111905"},{"key":"ref_188","unstructured":"European Association for the Study of the Liver (EASL), European Association for the Study of the Diabetes (EASD), and European Association for the Study of the Obesity (EASO) (2024). EASL\u2014EASD\u2014EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD). J. Hepatol., 81, 492\u2013542."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"G400","DOI":"10.1152\/ajpgi.00121.2020","article-title":"Mitochondrial oxidative injury: A key player in nonalcoholic fatty liver disease","volume":"319","author":"Dornas","year":"2020","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17460441.2018.1410135","article-title":"Non-alcoholic fatty liver disease (NAFLD) models in drug discovery","volume":"13","author":"Cole","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/17425255.2017.1246534","article-title":"Drug-induced steatohepatitis","volume":"13","author":"Dash","year":"2017","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"ref_193","doi-asserted-by":"crossref","unstructured":"Hansen, H.H., \u00c6gidius, H.M., Or\u00f3, D., Evers, S.S., Heeb\u00f8ll, S., Eriksen, P.L., Thomsen, K.L., Bengtsson, A., Veidal, S.S., and Feigh, M. (2020). Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterol., 20.","DOI":"10.1186\/s12876-020-01356-2"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1055\/a-1877-9656","article-title":"Nonalcoholic Steatohepatitis Drug Development Pipeline: An Update","volume":"42","author":"Chew","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"155937","DOI":"10.1016\/j.metabol.2024.155937","article-title":"Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease?","volume":"157","author":"Huttasch","year":"2024","journal-title":"Metabolism"},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.freeradbiomed.2025.02.017","article-title":"Regular exercise alleviates metabolic dysfunction-associated steatohepatitis through rescuing mitochondrial oxidative stress and dysfunction in liver","volume":"230","author":"Lin","year":"2025","journal-title":"Free Radic. Biol. Med."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial","volume":"35","author":"Ezpeleta","year":"2023","journal-title":"Cell Metab."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/apt.16608","article-title":"Randomised clinical trial: Semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging","volume":"54","author":"Flint","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_200","unstructured":"U.S. Food and Drug Administration (2026, June 19). FDA Approves Treatment for Serious Liver Disease Known as MASH, Available online: https:\/\/www.fda.gov\/drugs\/news-events-human-drugs\/fda-approves-treatment-serious-liver-disease-known-mash."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: A multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1111\/bph.15427","article-title":"Activation of thyroid hormone receptor-\u03b2 improved disease activity and metabolism independent of body weight in a mouse model of non-alcoholic steatohepatitis and fibrosis","volume":"178","author":"Kannt","year":"2021","journal-title":"Br. J. Pharmacol."},{"key":"ref_203","unstructured":"U.S. Food and Drug Administration (2026, June 19). FDA Approves First Treatment for Patients with Liver Scarring Due to Fatty Liver Disease, Available online: https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-first-treatment-patients-liver-scarring-due-fatty-liver-disease."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.2174\/0113816128374854250709050425","article-title":"FGF21 Analogues and MASLD: A Summary of Preclinical and Clinical Data","volume":"32","author":"Boutari","year":"2025","journal-title":"Curr. Pharm. Des."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/s41591-021-01425-3","article-title":"Efruxifermin in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled, phase 2a trial","volume":"27","author":"Harrison","year":"2021","journal-title":"Nat. Med."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2468-1253(22)00347-8","article-title":"Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: A randomised, double-blind, placebo-controlled, phase 1b\/2a multiple-ascending-dose study","volume":"8","author":"Loomba","year":"2023","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14656566.2024.2436595","article-title":"Tirzepatide for overweight and obesity management","volume":"26","author":"Hamza","year":"2025","journal-title":"Expert Opin. Pharmacother."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jhep.2024.08.009","article-title":"ACMSD inhibition corrects fibrosis, inflammation, and DNA damage in MASLD\/MASH","volume":"82","author":"Liu","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"113587","DOI":"10.1016\/j.celrep.2023.113587","article-title":"The mitochondrial genome-encoded peptide MOTS-c interacts with Bcl-2 to alleviate nonalcoholic steatohepatitis progression","volume":"43","author":"Lu","year":"2024","journal-title":"Cell Rep."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"101404","DOI":"10.1016\/j.jhepr.2025.101404","article-title":"Mitochondrial dysfunction characterises the multigenerational effects of maternal obesity on MASLD","volume":"7","author":"Heldens","year":"2025","journal-title":"JHEP Rep."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/liv.15163","article-title":"Ferroptosis and metabolic dysfunction-associated fatty liver disease: Is there a link?","volume":"42","author":"Feng","year":"2022","journal-title":"Liver Int."},{"key":"ref_213","doi-asserted-by":"crossref","unstructured":"Radosavljevic, T., Brankovic, M., Samardzic, J., Djureti\u0107, J., Vukicevic, D., Vucevic, D., and Jakovljevic, V. (2024). Altered Mitochondrial Function in MASLD: Key Features and Promising Therapeutic Approaches. Antioxidants, 13.","DOI":"10.3390\/antiox13080906"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s12967-022-03693-0","article-title":"Mitochondrial transplantation: Opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease","volume":"20","author":"Chen","year":"2022","journal-title":"J. Transl. Med."},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez, A., Arab, J.P., Reyes, D., Lapitz, A., Moshage, H., Ba\u00f1ales, J.M., and Arrese, M. (2020). Extracellular Vesicles in NAFLD\/ALD: From Pathobiology to Therapy. Cells, 9.","DOI":"10.3390\/cells9040817"},{"key":"ref_216","unstructured":"Feingold, K.R., Adler, R.A., Ahmed, S.F., Anawalt, B., Blackman, M.R., Chrousos, G., Corpas, E., de Herder, W.W., Dhatariya, K., and Dungan, K. (2000). Pathogenesis of Type 2 Diabetes Mellitus. Endotext, MDText.com, Inc."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1016\/j.cell.2022.09.031","article-title":"En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH","volume":"185","author":"Kimura","year":"2022","journal-title":"Cell"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.jhep.2021.08.012","article-title":"Epidemiology and risk-stratification of NAFLD-associated HCC","volume":"75","author":"Ioannou","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/s41574-021-00626-7","article-title":"Mitochondrial and metabolic dysfunction in ageing and age-related diseases","volume":"18","author":"Amorim","year":"2022","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat. Genet."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/ng.2901","article-title":"Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease","volume":"46","author":"Kozlitina","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1056\/NEJMoa1712191","article-title":"A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease","volume":"378","author":"Cheng","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Liu, J., Xiao, Y., Wu, X., Jiang, L., Yang, S., Ding, Z., Fang, Z., Hua, H., Kirby, M.S., and Shou, J. (2018). A circulating microRNA signature as noninvasive diagnostic and prognostic biomarkers for nonalcoholic steatohepatitis. BMC Genom., 19.","DOI":"10.1186\/s12864-018-4575-3"},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-022-00864-z","article-title":"Mitochondria homeostasis: Biology and involvement in hepatic steatosis to NASH","volume":"43","author":"Li","year":"2022","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1186\/s12967-023-04627-0","article-title":"Inflammatory signaling in NASH driven by hepatocyte mitochondrial dysfunctions","volume":"21","author":"Myint","year":"2023","journal-title":"J. Transl. Med."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/j.cmet.2021.09.008","article-title":"DRAK2 aggravates nonalcoholic fatty liver disease progression through SRSF6-associated RNA alternative splicing","volume":"33","author":"Li","year":"2021","journal-title":"Cell Metab."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"101122","DOI":"10.1016\/j.molmet.2020.101122","article-title":"Nonalcoholic fatty liver disease (NAFLD) from pathogenesis to treatment concepts in humans","volume":"50","author":"Pafili","year":"2021","journal-title":"Mol. Metab."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.7150\/thno.69826","article-title":"AGK regulates the progression to NASH by affecting mitochondria complex I function","volume":"12","author":"Ding","year":"2022","journal-title":"Theranostics"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.mce.2013.06.002","article-title":"Hepatic energy metabolism in human diabetes mellitus, obesity and non-alcoholic fatty liver disease","volume":"379","author":"Koliaki","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"G666","DOI":"10.1152\/ajpgi.00213.2016","article-title":"A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition","volume":"312","author":"Krishnan","year":"2017","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.jhep.2020.11.030","article-title":"Early changes in hepatic energy metabolism and lipid content in recent-onset type 1 and 2 diabetes mellitus","volume":"74","author":"Kupriyanova","year":"2021","journal-title":"J. Hepatol."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/hep.29085","article-title":"Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"65","author":"Dulai","year":"2017","journal-title":"Hepatology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jhep.2022.04.003","article-title":"Safety and efficacy of combination therapy with semaglutide, cilofexor and firsocostat in patients with non-alcoholic steatohepatitis: A randomised, open-label phase II trial","volume":"77","author":"Alkhouri","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_236","first-page":"S9","article-title":"Cholesterol and sphingolipids in alcohol-induced liver injury","volume":"23","author":"Colell","year":"2008","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.bbamem.2013.05.007","article-title":"Progressive stages of mitochondrial destruction caused by cell toxic bile salts","volume":"1828","author":"Schulz","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.molcel.2026.01.029","article-title":"The human antibacterial factor APOL3 couples lysosomal damage to mitochondrial DNA efflux and type I IFN induction","volume":"86","author":"Ritacco","year":"2026","journal-title":"Mol. Cell"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.molcel.2015.01.018","article-title":"Limited mitochondrial permeabilization causes DNA damage and genomic instability in the absence of cell death","volume":"57","author":"Ichim","year":"2015","journal-title":"Mol. Cell"}],"container-title":["Metabolites"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/7\/489\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T09:15:01Z","timestamp":1783934101000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2218-1989\/16\/7\/489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,11]]},"references-count":239,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["metabo16070489"],"URL":"https:\/\/doi.org\/10.3390\/metabo16070489","relation":{},"ISSN":["2218-1989"],"issn-type":[{"value":"2218-1989","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,11]]}}}